Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma

by S. C. Sasson, L. E. Wilkins, R. A. Watson, C. Jolly, O. Brain, P. Klenerman, A. Olsson-Brown, B. P. Fairfax
Published 2021-09-01

OA1-2 Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression

by G.E. Martin, M. Pace, J.P. Thornhill, C. Phetsouphanh, E. Hopkins, J. Meyerowitz, N. Nwokolo, J. Fox, C. Willberg, P. Klenerman, S. Fidler, J. Frater
Published 2017-07-01

CD161 Defines a Functionally Distinct Subset of Pro-Inflammatory Natural Killer Cells

by Ayako Kurioka, Cormac Cosgrove, Yannick Simoni, Bonnie van Wilgenburg, Alessandra Geremia, Sophia Björkander, Eva Sverremark-Ekström, Christine Thurnheer, Huldrych F. Günthard, Huldrych F. Günthard, Nina Khanna, The Swiss HIV Cohort Study, Oxford IBD Cohort Investigators, Lucy Jane Walker, Carolina V. Arancibia-Cárcamo, Evan W. Newell, Christian B. Willberg, Christian B. Willberg, Paul Klenerman, Paul Klenerman, V Aubert, M Battegay, E Bernasconi, J Böni, DL Braun, HC Bucher, C Burton-Jeangros, A Calmy, M Cavassini, G Dollenmaier, M Egger, L Elzi, J Fehr, J Fellay, H Furrer, CA Fux, M Gorgievski, H Günthard, D Haerry, B Hasse, HH Hirsch, M Hoffmann, I Hösli, C Kahlert, L Kaiser, O Keiser, T Klimkait, R Kouyos, H Kovari, B Ledergerber, G Martinetti, B Martinez de Tejada, C Marzolini, K Metzner, N Müller, D Nadal, D Nicca, G Pantaleo, A Rauch, S Regenass, C Rudin, A Scherrer, P Schmid, R Speck, M Stöckle, P Tarr, A Trkola, P Vernazza, R Weber, S Yerly, CV Arancibia-Cárcamo, A Bailey, E Barnes, B Bird-Lieberman, O Brain, B Braden, J Collier, J East, A Geremia, L Howarth, S Keshav, P Klenerman, S Leedham, R Palmer, F Powrie, A Rodrigues, A Simmons, P Sullivan, SPL Travis, H Uhlig
Published 2018-04-01